Female pattern hair loss Female pattern hair loss oral minoxidil topical minoxidil
Conditions
Interventions
oral minoxidil 1 mg per day for 48 weeks,5% topical minoxidil twice a day for 48 weeks
Experimental Drug,Active Comparator Drug
oral minoxidil 1 mg,5% topical minoxidil
Sponsors
Dermotology unit, King Chulalongkorn Memorial Hospital
Dermotology unit,
King Chulalongkorn Memorial Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Female patients, aged 18-65 year who were diagnosed with female pattern hair loss 2. History, clinical and dermoscope showed Savin scale I-4, II-1 and II-2 3. No treatment before or stop previous treatment at least 3 months prior to study
Exclusion criteria
Exclusion criteria: 1. patients who have other co-morbidity diseases which effect to hair density such as any malignancy, anemia, hypothyroidism/hyperthyroidism, AIDS and autoimmune connective tissue disease and who have cardiovascular disease 2. patients who have other scalp disease ex. seborrheic dermatitis, scalp psoriasis, tinea capitis. 3. patients who have history of hair transplantation or have large scar on scalp 4. patients who have history of minoxidil allergy 5. pregnancy or lactation women 6. on Hormonal therapy or spironolactone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of terminal hair density at start, 12weeks, 24 weeks, 36 weeks and 48 weeks after start intervention Using Fotofinder Dermatoscope for evaluation of terminal hair density at midscalp | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of total hair density at start, 12 weeks, 24 weeks, 36 weeks and 48 weeks after start intervention Using Fotofinder Dermatoscope for evaluation of total hair density at midscalp,Photographic assessment score at start, 24 weeks and 48 weeks after start intervention photographic assessment questionnaires,Satisfaction score at 24 weeks and 48 weeks after start intervention patient self-assessment questionnaires,Side effects at 4 weeks, 12 weeks, 24 weeks, 36 weeks and 48 weeks after start intervention questionnaires | — |
Countries
Thailand
Contacts
Public ContactRatchathorn Panchaprateep
Faculty of Medicine, Chulalongkorn university
Outcome results
None listed